Assessment of BRAF mutations and their predictive value in patients with advanced ...
Exploring biomarkers associated with clinical outcomes in melanoma patients treate...
Assessment of CD24 and NFIL3 expression in melanoma patients treated with immune c...
Beyond therapeutic boundaries in melanoma: unraveling biomarkers and strategies to...
Immune-checkpoint inhibitors: immunophenotyping and clinical outcome to predict re...
Hybrid dendritic-tumor cell immunotherapy in dogs with solid neoplasia: emphasis o...
Targeting the Warburg effect to overcome primary resistance to anti-PD-1/PD-L1 blo...